Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives $28.00 Average PT from Analysts

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) have been assigned an average rating of "Hold" from the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $28.00.

A number of brokerages have recently commented on SNN. Canaccord Genuity Group boosted their price target on Smith & Nephew SNATS from $27.00 to $28.00 and gave the company a "hold" rating in a report on Thursday, May 1st. Hsbc Global Res lowered Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. Finally, HSBC lowered Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a report on Friday, April 25th.

Smith & Nephew SNATS Stock Down 2.5%

Shares of Smith & Nephew SNATS stock traded down $0.78 during trading on Wednesday, reaching $30.29. The stock had a trading volume of 1,285,640 shares, compared to its average volume of 823,768. The company has a market capitalization of $13.27 billion, a price-to-earnings ratio of 14.02, a P/E/G ratio of 0.94 and a beta of 0.69. The stock has a fifty day moving average price of $29.30 and a two-hundred day moving average price of $27.42. Smith & Nephew SNATS has a 52 week low of $23.69 and a 52 week high of $31.72. The company has a current ratio of 2.89, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62.

Institutional Trading of Smith & Nephew SNATS

Several institutional investors and hedge funds have recently bought and sold shares of SNN. J. Goldman & Co LP bought a new stake in Smith & Nephew SNATS during the fourth quarter worth about $47,700,000. Armistice Capital LLC raised its holdings in Smith & Nephew SNATS by 258.1% during the first quarter. Armistice Capital LLC now owns 1,769,000 shares of the medical equipment provider's stock worth $50,187,000 after acquiring an additional 1,275,000 shares in the last quarter. River Road Asset Management LLC raised its holdings in Smith & Nephew SNATS by 64.0% during the fourth quarter. River Road Asset Management LLC now owns 2,032,016 shares of the medical equipment provider's stock worth $49,947,000 after acquiring an additional 792,829 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in Smith & Nephew SNATS by 49.2% during the first quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider's stock worth $50,255,000 after acquiring an additional 583,809 shares in the last quarter. Finally, Causeway Capital Management LLC bought a new stake in Smith & Nephew SNATS during the fourth quarter worth about $11,820,000. Institutional investors own 25.64% of the company's stock.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.